{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:03:12Z","timestamp":1778724192762,"version":"3.51.4"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:italic>Mycobacterium bovis<\/jats:italic>bacillus Calmette-Gue\u0301rin (BCG) currently remains the only licensed vaccine for the prevention of tuberculosis. In this study, we used a newly described flow cytometric technique to monitor changes in cell populations accumulating in the lungs and lymph nodes of nai\u0308ve and vaccinated guinea pigs challenged by low-dose aerosol infection with virulent<jats:italic>Mycobacterium tuberculosis<\/jats:italic>. As anticipated, vaccinated guinea pigs controlled the growth of the challenge infection more efficiently than controls did. This early phase of bacterial control in immune animals was associated with increased accumulation of CD4 and CD8 T cells, including cells expressing the activation marker CD45, as well as macrophages expressing class II major histocompatibility complex molecules. As the infection continued, the numbers of T cells in the lungs of vaccinated animals waned, whereas the numbers of these cells expressing CD45 increased. Whereas BCG vaccination reduced the influx of heterophils (neutrophils) into the lungs, an early B-cell influx was observed in these vaccinated animals. Overall, vaccine protection was associated with reduced pathology and lung damage in the vaccinated animals. These data provide the first direct evidence that BCG vaccination accelerates the influx of protective T-cell and macrophage populations into the infected lungs, diminishes the accumulation of nonprotective cell populations, and reduces the severity of lung pathology.<\/jats:p>","DOI":"10.1128\/cvi.00019-08","type":"journal-article","created":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T00:53:44Z","timestamp":1212022424000},"page":"1248-1258","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":43,"title":["Influence of<i>Mycobacterium bovis<\/i>BCG Vaccination on Cellular Immune Response of Guinea Pigs Challenged with<i>Mycobacterium tuberculosis<\/i>"],"prefix":"10.1128","volume":"15","author":[{"given":"Diane","family":"Ordway","sequence":"first","affiliation":[{"name":"Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Henao-Tamayo","sequence":"additional","affiliation":[{"name":"Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Shanley","sequence":"additional","affiliation":[{"name":"Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E.","family":"Smith","sequence":"additional","affiliation":[{"name":"Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopinath","family":"Palanisamy","sequence":"additional","affiliation":[{"name":"Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baolin","family":"Wang","sequence":"additional","affiliation":[{"name":"Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall J.","family":"Basaraba","sequence":"additional","affiliation":[{"name":"Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Orme","sequence":"additional","affiliation":[{"name":"Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.6.2951-2959.1998"},{"key":"e_1_3_2_3_2","first-page":"133","volume":"389","year":"1997","unstructured":"Behr, M. A., and P. M. Small. 1997. Has BCG attenuated to impotence? Nature389:133-134.","journal-title":"Nature"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4049\/jimmunol.131.3.1350","volume":"131","year":"1983","unstructured":"Burger, R., K. Reske, U. Mauer, D. von Steldern, and M. Husmann. 1983. Identification and characterization of gp TFA-1, a guinea pig T cell surface antigen associated with T cell function. J. Immunol.131:1350.","journal-title":"J. Immunol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","volume":"271","year":"1994","unstructured":"Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA271:698-702.","journal-title":"JAMA"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","volume":"163","year":"2003","unstructured":"Corbett, E. L., C. J. Watt, N. Walker, D. Maher, B. G. Williams, M. C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med.163:1009-1021.","journal-title":"Arch. Intern. Med."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","volume":"282","year":"1999","unstructured":"Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA282:677-686.","journal-title":"JAMA"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(06)68384-0","volume":"367","year":"2006","unstructured":"Dye, C. 2006. Global epidemiology of tuberculosis. Lancet367:938-940.","journal-title":"Lancet"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.93"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11908-007-0039-7","volume":"9","year":"2007","unstructured":"Friedland, G. 2007. Tuberculosis, drug resistance, and HIV\/AIDS: a triple threat. Curr. Infect. Dis. Rep.9:252-261.","journal-title":"Curr. Infect. Dis. Rep."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.2.1127-1133.2001"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1722-1728.2001"},{"key":"e_1_3_2_13_2","first-page":"415","volume":"100","year":"2006","unstructured":"Harries, A. D., and C. Dye. 2006. Tuberculosis. Ann. Trop. Med. Parasitol.100:415-431.","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"e_1_3_2_14_2","first-page":"377","volume":"77","year":"1992","unstructured":"Hart, I. J., H. Schafer, R. J. Scheper, and G. T. Stevenson. 1992. Subpopulations of guinea-pig T lymphocytes defined by isoforms of the leucocyte common antigen. Immunology77:377-384.","journal-title":"Immunology"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0022-1759(94)90398-0","volume":"170","year":"1994","unstructured":"Haverson, K., M. Bailey, V. R. Higgins, P. W. Bland, and C. R. Stokes. 1994. Characterization of monoclonal antibodies specific for monocytes, macrophages and granulocytes from porcine peripheral blood and mucosal tissues. J. Immunol. Methods170:233-245.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1172\/JCI31947","volume":"117","year":"2007","unstructured":"Hinchey, J., S. Lee, B. Y. Jeon, R. J. Basaraba, M. M. Venkataswamy, B. Chen, J. Chan, M. Braunstein, I. M. Orme, S. C. Derrick, S. L. Morris, W. R. Jacobs, and S. A. Porcelli. 2007. Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J. Clin. Investig.117:2279.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2567.2002.01422.x","volume":"106","year":"2002","unstructured":"Hiromatsu, K., C. C. Dascher, M. Sugita, C. Gingrich-Baker, S. M. Behar, K. P. LeClair, M. B. Brenner, and S. A. Porcelli. 2002. Characterization of guinea-pig group 1 cd1 proteins. Immunology106:159-172.","journal-title":"Immunology"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.1.213-224.2006"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000058699","volume":"70","year":"1998","unstructured":"Kaufmann, S. H. E., and P. Andersen. 1998. Immunity to mycobacteria with emphasis on tuberculosis: implications for rational design of an effective tuberculosis vaccine, p. 21-59. In F. Y. Liew and F. E. G. Cox (ed.), Immunology of intracellular parasitism,vol. 70. Karger, Basel, Switzerland.","journal-title":"Immunology of intracellular parasitism"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.11.7759-7764.2005"},{"key":"e_1_3_2_21_2","first-page":"523","volume":"65","year":"1988","unstructured":"Kraal, G., R. Shiamatey-Koolma, M. Hoffer, D. Baker, and R. Scheper. 1988. Histochemical identification of guinea-pig macrophages by monoclonal antibody Mr-1. Immunology65:523-528.","journal-title":"Immunology"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.10.5963-5971.2004"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1462-5822.2006.00854.x","volume":"9","year":"2007","unstructured":"Ly, L. H., M. I. Russell, and D. N. McMurray. 2007. Microdissection of the cytokine milieu of pulmonary granulomas from tuberculous guinea pigs. Cell. Microbiol.9:1127-1132.","journal-title":"Cell. Microbiol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2471\/BLT.06.037820","volume":"85","year":"2007","unstructured":"Maher, D., C. Dye, K. Floyd, A. Pantoja, K. Lonnroth, A. Reid, E. Nathanson, T. Pennas, U. Fruth, J. Cunningham, H. Ignatius, M. C. Raviglione, I. Koek, and M. Espinal. 2007. Planning to improve global health: the next decade of tuberculosis control. Bull. W. H. O.85:341-347.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4049\/jimmunol.173.1.494","volume":"173","year":"2004","unstructured":"Marino, S., S. Pawar, C. L. Fuller, T. A. Reinhart, J. L. Flynn, and D. E. Kirschner. 2004. Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis. J. Immunol.173:494-506.","journal-title":"J. Immunol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/00365540151060743","volume":"33","year":"2001","unstructured":"McMurray, D. N. 2001. Determinants of vaccine-induced resistance in animal models of pulmonary tuberculosis. Scand. J. Infect. Dis.33:175-178.","journal-title":"Scand. J. Infect. Dis."},{"key":"e_1_3_2_27_2","first-page":"157","volume":"215","year":"1996","unstructured":"McMurray, D. N., F. M. Collins, A. M. Dannenberg, Jr., and D. W. Smith. 1996. Pathogenesis of experimental tuberculosis in animal models. Curr. Top. Microbiol. Immunol.215:157-179.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tube.2005.08.012","volume":"85","year":"2005","unstructured":"McMurray, D. N., S. S. Allen, A. Jeevan, T. Lasco, H. Cho, T. Skwor, T. Yamamoto, C. McFarland, and T. Yoshimura. 2005. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis. Tuberculosis85:295-301.","journal-title":"Tuberculosis"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1189\/jlb.0607426","volume":"82","year":"2007","unstructured":"Ordway, D., D. M. Higgins, J. Sanchez-Campillo, J. Spencer, M. Henao-Tamayo, M. Harton, I. Orme, and M. Gonzalez-Juarrero. 2007. XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-\u03b3 by CD4 T cells and participates in granuloma stability. J. Leukoc. Biol.82:1221-1229.","journal-title":"J. Leukoc. Biol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.4049\/jimmunol.176.8.4931","volume":"176","year":"2006","unstructured":"Ordway, D., M. Harton, M. Henao-Tamayo, R. Montoya, I. M. Orme, and M. Gonzalez-Juarrero. 2006. Enhanced macrophage activity in granulomatous lesions of immune mice challenged with Mycobacterium tuberculosis. J. Immunol.176:4931-4939.","journal-title":"J. Immunol."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.4049\/jimmunol.179.4.2532","volume":"179","year":"2007","unstructured":"Ordway, D., G. Palanisamy, M. Henao-Tamayo, E. E. Smith, C. Shanley, I. M. Orme, and R. J. Basaraba. 2007. The cellular immune response to Mycobacterium tuberculosis infection in the guinea pig. J. Immunol.179:2532-2541.","journal-title":"J. Immunol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1472-9792(02)00069-0","volume":"83","year":"2003","unstructured":"Orme, I. M. 2003. The mouse as a useful model of tuberculosis. Tuberculosis (Edinburgh)83:112-115.","journal-title":"Tuberculosis (Edinburgh)"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vaccine.2005.07.078","volume":"24","year":"2006","unstructured":"Orme, I. M. 2006. Preclinical testing of new vaccines for tuberculosis: a comprehensive review. Vaccine24:2-19.","journal-title":"Vaccine"},{"key":"e_1_3_2_34_2","first-page":"1","year":"2004","unstructured":"Orme, I. M., and A. A. Izzo. 2004. TB vaccine preclinical screening and development, p. 1-38. In W. R. Jacobs, Jr. (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, DC.","journal-title":"Tuberculosis: pathogenesis, protection, and control."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0167-5699(98)01438-8","volume":"20","year":"1999","unstructured":"Orme, I. M., and A. M. Cooper. 1999. Cytokine\/chemokine cascades in immunity to tuberculosis. Immunol. Today20:307-312.","journal-title":"Immunol. Today"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jim.2006.01.010","volume":"311","year":"2006","unstructured":"Takizawa, M., J. Chiba, S. Haga, T. Asano, T. Yamazaki, N. Yamamoto, and M. Honda. 2006. Novel two-parameter flow cytometry (mil4\/ssc followed by mil4\/ct7) allows for identification of five fractions of guinea pig leukocytes in peripheral blood and lymphoid organs. J. Immunol. Methods311:47-56.","journal-title":"J. Immunol. Methods"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/hyb.1985.4.115","volume":"4","year":"1985","unstructured":"Tan, B. T., F. Ekelaar, J. Luirink, G. Rimmelzwaan, A. J. De Jonge, and R. J. Scheper. 1985. Production of monoclonal antibodies defining guinea pig T-cell surface markers and a strain 13 ia-like antigen: the value of immunohistological screening. Hybridoma4:115-124.","journal-title":"Hybridoma"},{"key":"e_1_3_2_38_2","first-page":"65","year":"2003","unstructured":"Turner, O. C., R. J. Basaraba, A. A. Frank, and I. M. Orme. 2003. Granuloma formation in mouse and guinea pig models of experimental tuberculosis, p. 65-84. In D. L. Boros (ed.), Granulomatous infections and inflammation: cellular and molecular mechanisms. ASM Press, Washington, DC.","journal-title":"Granulomatous infections and inflammation: cellular and molecular mechanisms."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.2.864-871.2003"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0008-8749(89)90176-7","volume":"120","year":"1989","unstructured":"Wilcox, C. E., D. Baker, C. Butter, D. A. Willoughby, and J. L. Turk. 1989. Differential expression of guinea pig class II major histocompatibility complex antigens on vascular endothelial cells in vitro and in experimental allergic encephalomyelitis. Cell. Immunol.120:82-91.","journal-title":"Cell. Immunol."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00019-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00019-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T20:27:47Z","timestamp":1708979267000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00019-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1128\/CVI.00019-08"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00019-08","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"2008-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-05-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}